Thrivent Financial for Lutherans’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Thrivent Financial for Lutherans’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-118,386	Closed	-$7.85M	–	1941
2014 Q3	$7.85M	Buy	118,386 +1,760	+2%	+$116K	0.05%	353
2014 Q2	$8.14M	Buy	116,626 +110,876	+1,928%	+$7.54M	0.05%	366
2014 Q1	$421K	Buy	5,750 +50	+0.9%	+$3.73K	﹤0.01%	1046
2013 Q4	$393K	Buy	5,700 +600	+12%	+$38.8K	﹤0.01%	1104
2013 Q3	$324K	Sell	5,100 -18,700	-79%	-$1.13M	﹤0.01%	1174
2013 Q2	$1.15K	Buy	+23,800	New	+$1.17M	0.01%	681

Other funds holding CBST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Thrivent Financial for Lutherans's CBST Position: Q4 2014 in Review

Thrivent Financial for Lutherans sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 118,386 shares — an estimated $7.85M sold.

Thrivent Financial for Lutherans first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $8.14M in Q2 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

Thrivent Financial for Lutherans reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
Thrivent Financial for Lutherans sold 118,386 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $7.85M.
Thrivent Financial for Lutherans first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
Thrivent Financial for Lutherans's CUBIST PHARMACEUTICALS INC position peaked at $8.14M in Q2 2014.
307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2014, filed 17 Feb 2015.